Table 3.
Self-reported outcomes of research bronchoscopy after 1 week
| COPD | Asthma | Controls | Comparison, COPD/controls | |
| n=122 | n=16 | n=101 | ||
| Willingness to return for research bronchoscopy* | 76.2% | 68.8% | 84.2% | p=0.213 |
| Fever sensation† | 45.9% | 37.5% | 51.5% | p=0.440 |
| Increased dyspnoea† | 31.4% | 25.0% | 13.9% | p=0.002 |
| Increased sputum† | 26.2% | 25.0% | 22.8% | p=0.540 |
| Change in sputum colour† | 20.7% | 25.0% | 12.9% | p=0.125 |
| Increased rhinitis† | 31.4% | 25.0% | 31.7% | p=0.965 |
| Increased wheezing respiration† | 24.8% | 12.5% | 7.9% | p=0.001 |
| Sore throat or coughing† | 54.1% | 56.3% | 57.4% | p=0.601 |
| Increased asthenia‡ | 37.2% | 31.3% | 27.0% | p=0.108 |
| Flu-like symptoms, including fever, muscle/joint pain, headache, reduced general condition* | 41.7% | 31.3% | 50.5% | p=0.189 |
| Discomfort graded from 0 to 10. Mean (SD)* | 4.2 (2.6) | 3.8 (2.8) | 4.2 (1.9) | p=0.364 |
| Exacerbation criteria fulfilled, total‡ | 45.5% | 37.5% | 33.0% | p=0.169 |
| Hospitalisation related to bronchoscopy§ | 0.8% | 12.5% | 1.0% | p=1.000 |
| Received treatment as if exacerbation (prednisolone/antibiotics)§ | 5.7% | 0.0% | 1.0% | p=0.076 |
*Two missing values (two COPD).
†One missing value (one COPD),
‡Two missing values (one COPD, one control).
§One missing value (one control).
COPD, chronic obstructive pulmonary disease.